Placental insufficiency (PI) is a complex pathophysiological condition caused by disruption of normal placental function, resulting in insufficient oxygen and nutrient supply to the fetus. This condition can have serious consequences for fetal development, including growth retardation, hypoxia, and even intrauterine death. Placental insufficiency can be caused by multiple factors, including both maternal and fetal diseases, and requires careful monitoring and treatment in obstetric practice.
History of the disease and interesting historical facts
Placental insufficiency has been known since ancient times, but the first scientific descriptions of this condition appeared only in the 19th century. One of the first to describe the clinical manifestations of placental insufficiency was the Austrian gynecologist and obstetrician Vincent Lieber, who in 1890 substantiated the connection between inadequate blood supply to the placenta and pathologies in newborns. Subsequently, research into the placenta and its role in pregnancy deepened significantly, and thanks to the work of scientists such as Friedrich Hoppe and Catherine Reisz, it was established that functional placental insufficiency can be caused by various diseases, including preeclampsia and diabetes.
Epidemiology
According to the World Health Organization, placental insufficiency occurs in approximately 10-15% of all pregnant women, but these rates may vary depending on the population and risk factors. In particular, in women with high risk factors such as preeclampsia or chronic diseases, the prevalence of placental insufficiency can reach 50%. In addition, in countries with developed health systems, early diagnosis and intervention occur, which helps reduce the level of complications associated with this condition.
Genetic predisposition to this disease
To date, genetic studies have shown that certain mutations and polymorphisms in genes responsible for angiogenesis and immune response may increase the risk of developing placental insufficiency. It is known that changes in the VEGFA, KDR, and FLT1 genes can lead to impaired vascular function of the placenta. In addition, hereditary factors such as polymorphisms in blood coagulation genes (for example, F2 and F5) may also be associated with a predisposition to placental insufficiency, causing thrombus formation and disrupting the blood supply to the placenta.
Risk factors for the development of this disease
Risk factors for placental insufficiency can be divided into physical and chemical. The main physical factors include:
- Mother's age (under 20 or over 35)
- Presence of chronic diseases (polyarthritis, diabetes, hypertension)
- Multiple pregnancies
- Previous cases of placental insufficiency
Chemical factors include:
- Smoking and alcohol
- The influence of toxic substances and drugs
- Poor nutrition and vitamin deficiency
In addition, socioeconomic factors such as low education and lack of health insurance are also significant in assessing risk.
Diagnosis of this disease
Diagnosis of placental insufficiency involves several stages and methods. The main symptoms of this condition may include:
- Fetal growth retardation
- Inadequate maternal weight gain
- Decreased volume of amniotic fluid
Laboratory tests include:
- General blood and urine tests
- Determination of protein levels in urine (to exclude preeclampsia)
- Biochemical parameters (liver enzymes, glucose levels, etc.)
Radiological examinations such as ultrasound play a key role in diagnosing and monitoring the condition of the fetus and placenta. These studies help assess blood flow, placental thickness, and other anatomical parameters.
Differential diagnosis should take into account various causes of fetal growth restriction, including infectious and chromosomal diseases.
Treatment
Treatment for placental insufficiency depends on the individual case and the severity of the condition. General approaches include:
- Monitoring the condition of the mother and fetus
- Maintaining optimal conditions for pregnancy
Pharmacological treatment may include:
- Antiplatelet drugs (eg, low-dose aspirin to improve circulation)
- Drugs to improve microcirculation (pentoxifylline)
Surgical treatment may be necessary in cases where the condition threatens the life of the mother or fetus, including in the presence of severe forms of preeclampsia.
List of medications used to treat this disease
- Low dose aspirin
- Heparin
- Pentoxifylline
- A nicotinic acid
Disease monitoring
Placental insufficiency monitoring includes regular ultrasound examinations to assess the condition of the fetus and placenta. Control stages should be carried out at least every two weeks, and more often if the condition worsens. The prognosis with timely diagnosis and intervention can be favorable, but advanced cases can lead to serious complications for both mother and child, including stillbirth and the development of respiratory distress syndrome.
Age-related features of the disease
Placental insufficiency can manifest itself differently in women of different age groups. In adolescents and women over 35, severe forms of this condition are more common. In the younger generation, placental insufficiency can be observed as a result of malnutrition or infections, while in older women, it is usually associated with concomitant chronic diseases.
Questions and Answers
- What is placental insufficiency? Placental insufficiency is a condition in which the placenta cannot provide the fetus with enough oxygen and nutrients, which can lead to serious complications for the unborn child.
- What factors increase the risk of placental insufficiency? Major risk factors include maternal age, chronic illnesses, smoking, drug use, multiple pregnancies, and previous cases of placental insufficiency.
- How is placental insufficiency diagnosed? Diagnosis of placental insufficiency includes analysis of clinical symptoms, laboratory tests and ultrasound examination, which allows assessing the condition of the placenta and fetus.
- How to treat placental insufficiency? Treatment may include pharmacological drugs to improve microcirculation and prevent thrombus formation, as well as monitoring the condition of the mother and child.
- What is the prognosis for placental insufficiency? The prognosis depends on the severity of the condition and the timeliness of intervention; with early diagnosis and adequate treatment, the chances of a favorable outcome are significantly increased.
